￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the indications of fezolinetant and introduction to the applicable patient population?

2026-02-01 22:25:32

Check Details
Will belumosudil be included in medical insurance in 2025 and interpretation of related policies

2026-02-01 22:25:32

Check Details
Standard Guidelines for Recommended Dosage and Administration of Brivaracetam

2026-02-01 22:25:32

Check Details
Analysis of price trends and market supply of domestic obeticholic acid (Obeticholic)

2026-02-01 22:25:32

Check Details
How much does it cost to take neratinib for one year and what is the medical insurance coverage?

2026-02-01 22:25:32

Check Details
Is Adalimumab required for long-term maintenance in rheumatoid arthritis?

2026-02-01 22:25:32

Check Details
Which cancers is Tislelizumab suitable for?

2026-02-01 22:25:32

Check Details
Can Ustekinumab be used again after 3 years of discontinuation?

2026-02-01 22:25:32

Check Details
Is Tarlatamab a targeted therapy drug?

2026-02-01 22:25:32

Check Details
Is Elafibranor treatment experience feedback good or not?

2026-02-01 22:25:32

Check Details
The reason why Thiotepa is known as a specific drug for treating tumors

2026-02-01 22:25:32

Check Details
Capmatinib, the world’s first new MET-targeting drug: mechanism analysis, medication guide and Chinese and foreign prices revealed

2026-02-01 22:25:32

Check Details
Category
相关知识